FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signalingResearch in context
Background: The resistance to EGF receptor (EGFR) tyrosine kinase inhibitors (TKI) is a major challenge in the treatment of non-small cell lung cancer (NSCLC). Understanding the molecular mechanisms behind resistance is therefore an important issue. Here we assessed the role of EGFR pathway substrat...
Main Authors: | Qiang Wen, Xinwei Jiao, Fei Kuang, Beibei Hou, Yajing Zhu, Wenyu Guo, Guangxin Sun, Yufeng Ba, Dandan Yu, David Wang, Faya Zhang, Hui Chao Qiao, Shuolin Wang, Shu Tang, Hailing Qiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419300611 |
Similar Items
-
FoxO gene family evolution in vertebrates
by: Wang Qishan, et al.
Published: (2009-09-01) -
Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese.
by: Ying Zhao, et al.
Published: (2014-01-01) -
Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signalingResearch in context
by: Na Wang, et al.
Published: (2019-09-01) -
FoxO Proteins in the Nervous System
by: Kenneth Maiese
Published: (2015-01-01) -
Immunohistochemical detections of EGFR status in NSCLC
by: Jie WANG, et al.
Published: (2015-04-01)